Results 181 to 190 of about 3,184,534 (315)

Heparin-Based Biomaterials for Sustained Release of Growth Factors for Bone Tissue Engineering and Regeneration. [PDF]

J Funct Biomater
Nakayama K, Gao X, Force BS, Philippon MJ, Huard J.   +4 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

A QUANTITATIVE ASSESSMENT OF FACTORS CONTRIBUTING TO THE ECONOMIC GROWTH OF MICHIGAN REGIONS

Many studies in regional development and economic geography are focused on factors that determine regional growth. In this paper a review of existing studies of regional growth is presented.
Nizalov, Denys
core  

Growth and Growth Factors [PDF]

, 2007
Evelien F Gevers, Peter C Hindmarsh, Mehul T Dattani   +2 more
openaire   +1 more source

Biological impact of adding albumin and silver nanoparticles to concentrated growth factors. [PDF]

BMC Oral Health
Alshirah AA, Elnaem MH, Al-Ani Z, Banat IM, O'Hagan BMG, Lowry D, Ternan NG, Almasri M, McCarron PA.   +8 more
europepmc   +1 more source

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect

Frontiers in Molecular Neuroscience, 2018
Illana Gozes, Yanina Ivashko-Pachima, Carmen L. Sayas   +2 more
doaj   +1 more source

A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors. [PDF]

Cent European J Urol
Abdelrahman IFS, Raheem AA, Elbitar M, Fahmy H, ZaaZaa A, Adel A, Gadalla A, AbdElSalam MA.   +7 more
europepmc   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source

Diagnostic applicability of the circulating growth factors in preeclampsia. [PDF]

Sci Rep
Kim HY, Moon S, Song KH, Kim HJ.
europepmc   +1 more source